Login / Signup

High-resolution snapshots of human N-myristoyltransferase in action illuminate a mechanism promoting N-terminal Lys and Gly myristoylation.

Cyril DianInmaculada Pérez-DoradoFrédéric RivièreThomas AsensioPierre LegrandMarkus RitzefeldMengjie ShenErnesto CotaThierry MeinnelEdward William TateCarmela Giglione
Published in: Nature communications (2020)
The promising drug target N-myristoyltransferase (NMT) catalyses an essential protein modification thought to occur exclusively at N-terminal glycines (Gly). Here, we present high-resolution human NMT1 structures co-crystallised with reactive cognate lipid and peptide substrates, revealing high-resolution snapshots of the entire catalytic mechanism from the initial to final reaction states. Structural comparisons, together with biochemical analysis, provide unforeseen details about how NMT1 reaches a catalytically competent conformation in which the reactive groups are brought into close proximity to enable catalysis. We demonstrate that this mechanism further supports efficient and unprecedented myristoylation of an N-terminal lysine side chain, providing evidence that NMT acts both as N-terminal-lysine and glycine myristoyltransferase.
Keyphrases
  • high resolution
  • endothelial cells
  • mass spectrometry
  • induced pluripotent stem cells
  • pluripotent stem cells
  • amino acid
  • high speed
  • fatty acid
  • liquid chromatography
  • data analysis